Skip to main content

Gilead signals beyond the news: 45+ signals from 6 sources

The latest Gilead signal on this page is from Nov 17, 2026 (Patents): "Gilead Sciences was granted a patent for PRMT5-inhibiting cancer medicines." The busiest sources: Glassdoor (15+), Website changes (12) and Employee growth (7).

Public (GILD)Biotechnology Research10,000+ employeesgilead.comLinkedIn

Get Gilead's live signals in Claude or ChatGPT, or by API

AskWhat changed at Gilead this week? Use Autobound signals for gilead.com.
Signals
45+
Sources
6
Last 90 days
25
Latest
Nov 17, 2026

Source: Autobound Signal API · 74 signals tracked for Gilead · updated

Other signals · latest 10

Latest Gilead signals by source

45+ signals for Gilead across 6 sources.

  1. Patents · Patent grant

    Gilead Sciences was granted a patent for PRMT5-inhibiting cancer medicines.

    In November 2026 Gilead Sciences patented drug compounds intended for treating cancers and other conditions involving chromosome 9p21 deletion or MTAP loss.

    Patent title
    PRMT5 inhibitors and uses thereof
    Grant date
    Nov 17, 2026
    Inventors
    Megan K. Armstrong, Elbert Chin, Chienhung Chou, Laurent P. Debien

    Google Patents

  2. Patents · Patent pace

    Gilead Sciences, Inc.'s patent output is accelerating: 38 grants in the past year, 4 in the past 30 days.

    Over the past year Gilead Sciences, Inc. received 38 US patent grants; the recent pace (6 in 90 days) is accelerating versus its trailing baseline.

    Grants, 12 months
    38
    Grants, 90 days
    6
    Grants, 30 days
    4
    Pace
    Accelerating

    Google Patents

  3. Glassdoor · Cross functional collaboration issues

    Large organization struggles with coordination and decision making across internal teams

    Long-term staff note that navigating across teams and functions takes significant time, requiring increased coordination for effective decision making.

    Overall rating
    3.6 of 5
    CEO approval
    74%
    Reviews read
    9
    Review window
    Oct 15, 2026 to Nov 8, 2026

    Glassdoor

  4. Glassdoor · Growth opportunities

    Staff across roles report limited career development and promotion paths

    Employees ranging from tablet inspectors to corporate staff describe difficulty in moving up or receiving promotions, noting that advancement is often stagnant.

    Overall rating
    3.6 of 5
    CEO approval
    74%
    Reviews read
    9
    Review window
    Oct 15, 2026 to Nov 8, 2026

    Glassdoor

  5. Website changes · Website update

    Gilead added a prominent link directing visitors to its therapeutic areas page, indicating increased emphasis on showcasing its therapeutic areas and scientific capabilities.

    Added: “Learn more” linking to “/science/therapeutic-areas” alongside the new “TRANSFORMING SCIENCE INTO POSSIBILITY” message.

    Page
    /

    gilead.com

  6. Website changes · Marketing campaign

    Gilead replaced its homepage messaging about enabling global access to investigational once-yearly lenacapavir with a broader positioning focused on transforming science into the potential of...

    Removed: “ENABLING FUTURE GLOBAL ACCESS Gilead is helping advance manufacturing readiness and supply planning to help enable broad, sustainable access to investigational once-yearly lenacapavir, if approved.” Added: “TRANSFORMING SCIENCE INTO POSSIBILITY We rise to the challenge of addressing the world’s most...

    Page
    /

    gilead.com

  7. Reddit · Customer feedback

    A Goldman Sachs analyst report highlighted that Gilead's Hepatitis C cure is projected to generate less than $4 billion in annual revenue, down from a cumulative total of $73 billion, questioning...

    Post: "“Is curing patients a sustainable business model?” Goldman Sachs analysts ask. Analyst report notes that Gilead’s hep C cure will make less than $4 billion..."

    Subreddit
    r/biotech
    Upvotes
    300
    Comments
    59
    Sentiment
    Neutral

    r/biotech

  8. Reddit · Product launch

    The U.S.

    Post: "GILD | U.S. FDA Approves Gilead’s Bixlenvo™, a New Once-Daily Single Tablet Option for Virologically Suppressed Adults With HIV, Including Those on Complex..."

    Subreddit
    r/StockTitan
    Upvotes
    2
    Comments
    0
    Sentiment
    Positive

    r/StockTitan

  9. Podcasts · Tech adoption

    AUTM on the Air discusses Gilead: tech adoption

    "In the case of Gilead, actually Remdesivir, or the treatment of COVID-19, is one of the medications that use the Captisol technology."

    Podcast
    AUTM on the Air
    Episode
    Advancing Biopharma Innovation with Ruben Flores-Saaib
    Speaker
    Ruben Flores-Saaib
    Speaker role
    Counterparty

    AUTM on the Air

  10. Employee growth · Headcount change

    Slow growth (0% YoY) for a enterprise company with 14,493 employees.

    Company's 0% headcount growth represents slow expansion for a enterprise company. This adds approximately 0 employees lost over the past year.

    Total headcount
    14,493
    Company growth, 1 year
    0%
    Median tenure
    5 years

Showing 10 of 45+ signals. The Signal API returns all of them.

Get them with one API call

Signal API · MCP

Track Gilead with the Signal API

One POST /v1/companies/enrich call with gilead.com returns Gilead signals from 14 more signal types (reddit-company, podcast-company, glassdoor-company and more), each with its source. Or ask Claude through MCP.

2 credits per signal returned; zero-result calls are free. Endpoint reference

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{
    "domain": "gilead.com",
    "signal_types": ["reddit-company","podcast-company","glassdoor-company",
      "product-reviews","linkedin-post-company","twitter-company-posts",
      "youtube-company","website-intelligence","patents-company",
      "federal-contract-award","conference-speaker","hackernews",
      "producthunt-launch","seo-traffic"],
    "limit": 20
  }'

Bulk data

Need these signals for 10,000+ companies?

Get a free sample file or a bulk feed (API, GCS push, flat file).

Talk to sales

Same industry

Questions about Gilead other signals

What signals does Autobound track for Gilead besides news and filings?
This page lists 45+ signals for Gilead from 6 sources: Glassdoor (15+), Website changes (12), Employee growth (7), Patents (6), Reddit (3) and Podcasts (2). Every row is dated, and most link to the post, review or record.
What are people saying about Gilead online?
The newest posts on this page: Sep 23, 2026, Reddit (r/biotech): A Goldman Sachs analyst report highlighted that Gilead's Hepatitis C cure is projected to generate less than $4 billion in annual revenue, down from a cumulative total of $73 billion, questioning... Aug 27, 2026, Reddit (r/StockTitan): The U.S. Aug 27, 2026, Reddit (r/NBCauto): The FDA approved a new daily HIV pill from Gilead designed to simplify treatment for certain patients.
What do employees say about working at Gilead?
The newest Glassdoor theme on this page, dated Nov 8, 2026: Large organization struggles with coordination and decision making across internal teams. The overall rating in that row is 3.6 of 5. Themes summarize recent reviews; read the reviews on Glassdoor for the full picture.
Has Gilead been granted patents recently?
Yes. The newest grant on this page: Nov 17, 2026, Patents (Google Patents): Gilead Sciences was granted a patent for PRMT5-inhibiting cancer medicines.

Page updated , the date of the newest row on this page.

Source. Reddit, podcasts, Glassdoor, product reviews, LinkedIn, X, YouTube, company websites, patents, federal contracts, conference talks, Hacker News, Product Hunt, web traffic and employee growth, from the Signal API.

Method. The latest 15 signals per source from the last 12 months. Posts that do not name the company, replies, repeats and unreadable rows are removed. Traffic and headcount keep their newest measure.

Data as of .

How this data is built →Get it from the Signal API →